Medicine and Dentistry
Pancreas Cancer
100%
Pancreas Adenocarcinoma
66%
Stereotactic Body Radiation Therapy
56%
Overall Survival
46%
Magnetic Resonance Imaging
37%
Gimeracil Plus Oteracil Potassium Plus Tegafur
33%
Radiation Therapy
33%
Gemcitabine
33%
Diffusion MRI
33%
Surgery
26%
Disease
17%
Adverse Event
12%
Chemoradiotherapy
11%
Capecitabine
11%
Biological Marker
8%
Adenocarcinoma
6%
Jaundice
6%
Progressive Disease
6%
Progression Free Survival
6%
Constipation
6%
Duodenum
6%
Combination Chemotherapy
6%
Nausea and Vomiting
6%
Image-Guided Intervention
6%
Hand Foot Syndrome
5%
Randomized Controlled Trial
5%
Malignant Neoplasm
5%
Adjuvant Therapy
5%
Cohort Study
5%
Metastatic Carcinoma
5%
Clinical Trial
5%
Febrile Neutropenia
5%
Chemotherapy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Adenocarcinoma
66%
Pancreas Cancer
66%
Gimeracil Plus Oteracil Potassium Plus Tegafur
33%
Gemcitabine
33%
Overall Survival
33%
Chemoradiation Therapy
11%
Capecitabine
11%
Disease
11%
Biological Marker
8%
Chemotherapy
5%
Febrile Neutropenia
5%
Metastasis
5%
Cohort Study
5%
Hand Foot Syndrome
5%
Clinical Trial
5%
Randomized Controlled Trial
5%
Adverse Event
5%
Malignant Neoplasm
5%